Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04496089
What this trial is testing

Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC

Who this might be right for
Carcinoma, Renal CellClear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 6
Early research (Phase 1)Study completedNCT00004095
What this trial is testing

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
Northwestern University 38
Early research (Phase 1)Looking for participantsNCT07072234
What this trial is testing

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell CarcinomaPhase 1Growth Factor
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT00019630
What this trial is testing

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Soft Tissue SarcomaChildhood Liver CancerBone Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00448149
What this trial is testing

Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
The Methodist Hospital Research Institute 55
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT02334709
What this trial is testing

Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.

Who this might be right for
Carcinoma, Renal Cell
University Hospital, Ghent 13
Testing effectiveness (Phase 2)Ended earlyNCT00672178
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)

Who this might be right for
Renal Cell Carcinoma
Duke University 1
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Early research (Phase 1)Study completedNCT01281488
What this trial is testing

Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors

Who this might be right for
Recurrent Renal Cell CancerStage I Renal Cell CancerStage II Renal Cell Cancer
City of Hope Medical Center 28
Early research (Phase 1)Study completedNCT00513851
What this trial is testing

Phase 1 Study of OSI-930 in Cancer Patients

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Early research (Phase 1)Active Not RecruitingNCT01480154
What this trial is testing

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmStage III Cutaneous Melanoma AJCC v7Stage III Prostate Cancer AJCC v7+7 more
National Cancer Institute (NCI) 62
Not applicableEnded earlyNCT02170389
What this trial is testing

Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell Cancer
Roswell Park Cancer Institute 5
Early research (Phase 1)Study completedNCT03775850
What this trial is testing

EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Who this might be right for
Colorectal Cancer MetastaticTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more
Evelo Biosciences, Inc. 69
Early research (Phase 1)Ended earlyNCT02410174
What this trial is testing

To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors

Who this might be right for
Primary TumorRenal Cell Carcinoma
Beth Israel Medical Center 3
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)WithdrawnNCT02567396
What this trial is testing

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Estrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT01004783
What this trial is testing

Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors

Who this might be right for
Kidney Cancer
Children's Oncology Group 165
Next Page